\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\:\\	1\\.\\ a\\ 5x7mm\\ erythematous\\,firm\\,\\ exophytic\\ growth\\ was\\ present\\ on\\ his\\ distal\\ forearm\\.\ \(0\)\
\-\ 2\\.\\ a\\ firm\\ 1x1\\.5cm\\ pedunculated\\ flesh\\-colored\\ mass\ \(0\)\
\-\ was\\ present\\ on\\ the\\ right\\ side\\ of\\ his\\ neck\\.\\ \ \(1\)\
\-\ 3\\.\\ adenoid\\ facies\\ was\\ observed\\.\\ \ \(0\)\
\-\ 4\\.\\ a\\ high\\-arched\\ palate\\ was\\ present\\.\\ \ \(0\)\
\-\ 5\\.\\ there\\ was\\ a\\ light\\ flesh\\-colored\\ to\\ white\\ 2x3mm\\ papule\\ on\\ his\\ left\\ nasal\\ alar\\ fold\\.\ \(0\)\
\-\ \\ laboratory\\:\\ none\ \(0\)\
\-\ patient\\ has\\ been\\ healthy\\ throughout\\ his\\ period\\ of\\ observation\\.\\ evaluation\\ by\\ the\\ gi\\-service\\ has\\ revealed\\ the\\ presence\\ of\\ multiple\\ hamartomatous\\ polyps\\ in\\ his\\ esophagus\\,\\ stomach\\,\\ and\\ colon\\.\\ he\\ is\\ being\\ followed\\ by\\ endocrinology\\ for\\ his\\ thyroid\\ disease\\ and\\ to\\ screen\\ for\\ development\\ of\\ thyroid\\ cancer\\.\ \(0\)\
\-\ histopathology\\:\\ 1\\.\\ left\\ forearm\\ \\-\\ sclerotic\\ fibroma\\	2\\.\\ right\\ neck\\ \\-\\ sclerotic\\ fibroma\\ 3\\.\\ left\\ nasal\\ ala\\ \\-\\ fibrous\\ papule\ \(0\)\
\-\ cowden\\'s\\ syndrome\\ \\(1997\\ uniformed\\ services\\ dermatology\\ seminar\\,\\ case\\#21b\\)\\ submitted\\ by\\:\\ lt\\ charles\\ miller\\,\\ mc\\,\\ usnr\ \(0\)\
\-\ patient\\ referred\\ to\\ rule\\ out\\ a\\ keratoacanthoma\\ on\\ his\\ left\\ forearm\\.\\ lesion\\ had\\ been\\ present\\ 10\\ years\\ but\\ had\\ recently\\ started\\ enlarging\\ over\\ the\\ last\\ six\\ months\\.\\ he\\ also\\ requested\\ removal\\ of\\ a\\ \\"mole\\"\\ on\\ his\\ right\\ neck\\.\\ his\\ pmh\\ was\\ significant\\ for\\ hashimoto\\'s\\ thyroiditis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ his\\:\\ 0\\.10262037615195549\ \(0\)\
\-\ flesh\\-colored\\:\\ 0\\.07145283458609618\ \(0\)\
\-\ forearm\\:\\ 0\\.06896348364245056\ \(0\)\
\-\ papule\\:\\ 0\\.06360748402695542\ \(0\)\
\-\ fibroma\\:\\ 0\\.044028476050185915\ \(0\)\
\-\ 5x7mm\\:\\ 0\\.04081258529614119\ \(0\)\
\-\ 1x1\\.5cm\\:\\ 0\\.04081258529614119\ \(0\)\
\-\ high\\-arched\\:\\ 0\\.04081258529614119\ \(0\)\
\-\ 2x3mm\\:\\ 0\\.04081258529614119\ \(0\)\
\-\ gi\\-service\\:\\ 0\\.04081258529614119\ \(0\)\
\-\ 21b\\:\\ 0\\.04081258529614119\ \(0\)\
\-\ nasal\\:\\ 0\\.039171768011999314\ \(0\)\
\-\ firm\\:\\ 0\\.03880134824705765\ \(0\)\
\-\ present\\:\\ 0\\.03574090285058668\ \(0\)\
\-\ keratoacanthoma\\:\\ 0\\.03572641729304809\ \(0\)\
\-\ sclerotic\\:\\ 0\\.03541746145544224\ \(0\)\
\-\ neck\\:\\ 0\\.0348505991252567\ \(0\)\
\-\ alar\\:\\ 0\\.03439455584651207\ \(0\)\
\-\ ala\\:\\ 0\\.03251740256823353\ \(0\)\
\-\ thyroid\\:\\ 0\\.03242881893448806\ \(0\)\
\-\ usnr\\:\\ 0\\.03180374201347771\ \(0\)\
\-\ hamartomatous\\:\\ 0\\.031185541121697507\ \(0\)\
\-\ cowden\\:\\ 0\\.030640249289954992\ \(0\)\
\-\ mole\\:\\ 0\\.030152469124872464\ \(0\)\
\-\ facies\\:\\ 0\\.029711218292445035\ \(0\)\
\-\ miller\\:\\ 0\\.029711218292445035\ \(0\)\
\-\ hashimoto\\:\\ 0\\.028594727288663146\ \(0\)\
\-\ endocrinology\\:\\ 0\\.028275315846593922\ \(0\)\
\-\ adenoid\\:\\ 0\\.027976526396882945\ \(0\)\
\-\ palate\\:\\ 0\\.027976526396882945\ \(0\)\
\-\ was\\:\\ 0\\.02745215339482463\ \(0\)\
\-\ 3\\.\\:\\ 0\\.0270729093716734\ \(0\)\
\-\ lt\\:\\ 0\\.026943454400057902\ \(0\)\
\-\ fold\\:\\ 0\\.02629640837054328\ \(0\)\
\-\ \\-\\:\\ 0\\.025440673037616157\ \(0\)\
\-\ 2\\.\\:\\ 0\\.02516151983148387\ \(0\)\
\-\ pedunculated\\:\\ 0\\.02506630112177936\ \(0\)\
\-\ thyroiditis\\:\\ 0\\.02491449638648774\ \(0\)\
\-\ 1\\.\\:\\ 0\\.02471471450275556\ \(0\)\
\-\ exophytic\\:\\ 0\\.024095372737603118\ \(0\)\
\-\ polyps\\:\\ 0\\.02397190863074126\ \(0\)\
\-\ submitted\\:\\ 0\\.023399621797559885\ \(0\)\
\-\ mc\\:\\ 0\\.023189147843500825\ \(0\)\
\-\ requested\\:\\ 0\\.023087393645728718\ \(0\)\
\-\ erythematous\\:\\ 0\\.02298782788081685\ \(0\)\
\-\ screen\\:\\ 0\\.02298782788081685\ \(0\)\
\-\ charles\\:\\ 0\\.022345066562047333\ \(0\)\
\-\ 1997\\:\\ 0\\.02217669783903402\ \(0\)\
\-\ histopathology\\:\\ 0\\.022094755352462723\ \(0\)\
\-\ he\\:\\ 0\\.022075808722527956\ \(0\)\
\-\ seminar\\:\\ 0\\.022014238025092957\ \(0\)\
\-\ uniformed\\:\\ 0\\.021780761850894382\ \(0\)\
\-\ been\\:\\ 0\\.021525878606148064\ \(0\)\
\-\ services\\:\\ 0\\.02134641576192376\ \(0\)\
\-\ dermatology\\:\\ 0\\.02134641576192376\ \(0\)\
\-\ \\:\\:\\ 0\\.020931015110938242\ \(0\)\
\-\ observation\\:\\ 0\\.02029954456075548\ \(0\)\
\-\ enlarging\\:\\ 0\\.02013708474681442\ \(0\)\
\-\ by\\:\\ 0\\.019762095878401036\ \(0\)\
\-\ pmh\\:\\ 0\\.019681343668975285\ \(0\)\
\-\ six\\:\\ 0\\.01944628660706129\ \(0\)\
\-\ observed\\:\\ 0\\.01896768311421946\ \(0\)\
\-\ period\\:\\ 0\\.018496466936858615\ \(0\)\
\-\ light\\:\\ 0\\.01845928095677869\ \(0\)\
\-\ recently\\:\\ 0\\.01845928095677869\ \(0\)\
\-\ healthy\\:\\ 0\\.017836452748641624\ \(0\)\
\-\ left\\:\\ 0\\.017705653134683606\ \(0\)\
\-\ started\\:\\ 0\\.017646167213060365\ \(0\)\
\-\ stomach\\:\\ 0\\.017493360284966987\ \(0\)\
\-\ \\'s\\:\\ 0\\.017444876095991158\ \(0\)\
\-\ development\\:\\ 0\\.017230408440554332\ \(0\)\
\-\ growth\\:\\ 0\\.017202092574732868\ \(0\)\
\-\ esophagus\\:\\ 0\\.017173948842897767\ \(0\)\
\-\ had\\:\\ 0\\.017072683511488038\ \(0\)\
\-\ 5\\.\\:\\ 0\\.017063054208534375\ \(0\)\
\-\ last\\:\\ 0\\.01690153912056937\ \(0\)\
\-\ on\\:\\ 0\\.01675673639734787\ \(0\)\
\-\ rule\\:\\ 0\\.01652080718428709\ \(0\)\
\-\ fibrous\\:\\ 0\\.015991788232671632\ \(0\)\
\-\ removal\\:\\ 0\\.015596208575463833\ \(0\)\
\-\ 4\\.\\:\\ 0\\.015576296159262952\ \(0\)\
\-\ colon\\:\\ 0\\.015536726434362682\ \(0\)\
\-\ \\#\\:\\ 0\\.015517067680281889\ \(0\)\
\-\ referred\\:\\ 0\\.014928386312294635\ \(0\)\
\-\ has\\:\\ 0\\.014858333060132203\ \(0\)\
\-\ throughout\\:\\ 0\\.014809015399536697\ \(0\)\
\-\ laboratory\\:\\ 0\\.014579128406731786\ \(0\)\
\-\ presence\\:\\ 0\\.01436011860396819\ \(0\)\
\-\ being\\:\\ 0\\.013786055448150732\ \(0\)\
\-\ side\\:\\ 0\\.013705770841500327\ \(0\)\
\-\ 10\\:\\ 0\\.013336223279383844\ \(0\)\
\-\ followed\\:\\ 0\\.013263314219346163\ \(0\)\
\-\ white\\:\\ 0\\.01312085283662971\ \(0\)\
\-\ out\\:\\ 0\\.01307432350397461\ \(0\)\
\-\ cancer\\:\\ 0\\.013005394742429469\ \(0\)\
\-\ revealed\\:\\ 0\\.01269663837900969\ \(0\)\
\-\ right\\:\\ 0\\.012522662626533565\ \(0\)\
\-\ years\\:\\ 0\\.011616866375085567\ \(0\)\
\-\ evaluation\\:\\ 0\\.011491846276975961\ \(0\)\
\-\ syndrome\\:\\ 0\\.011314382299697414\ \(0\)\
\-\ a\\:\\ 0\\.011016661161627812\ \(0\)\
\-\ months\\:\\ 0\\.010805283771713274\ \(0\)\
\-\ distal\\:\\ 0\\.010755919393268643\ \(0\)\
\-\ significant\\:\\ 0\\.010638181254880663\ \(0\)\
\-\ for\\:\\ 0\\.010126502064482153\ \(0\)\
\-\ over\\:\\ 0\\.010072419398796122\ \(0\)\
\-\ none\\:\\ 0\\.009813516235685216\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.009722847396443596\ \(0\)\
\-\ physical\\:\\ 0\\.009706042914727955\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.009535877323991864\ \(0\)\
\-\ \\,\\:\\ 0\\.008773011382504683\ \(0\)\
\-\ exam\\:\\ 0\\.00869089787013675\ \(0\)\
\-\ case\\:\\ 0\\.008655113115126253\ \(0\)\
\-\ but\\:\\ 0\\.008437515282562674\ \(0\)\
\-\ multiple\\:\\ 0\\.00833243520129291\ \(0\)\
\-\ lesion\\:\\ 0\\.008058126046298401\ \(0\)\
\-\ patient\\:\\ 0\\.007931406767744332\ \(0\)\
\-\ also\\:\\ 0\\.00779916478550996\ \(0\)\
\-\ disease\\:\\ 0\\.0064663775056282595\ \(0\)\
\-\ to\\:\\ 0\\.0059315015061525865\ \(0\)\
\-\ there\\:\\ 0\\.005887572020671244\ \(0\)\
\-\ mass\\:\\ 0\\.00550213429142391\ \(0\)\
\-\ \\(\\:\\ 0\\.0033442672511289837\ \(0\)\
\-\ \\)\\:\\ 0\\.0033034152412653012\ \(0\)\
\-\ of\\:\\ 0\\.0026968472406941764\ \(0\)\
\-\ is\\:\\ 0\\.0026031980480774332\ \(0\)\
\-\ the\\:\\ 0\\.002560171938956033\ \(0\)\
\-\ \\.\\:\\ 0\\.001972196449852571\ \(0\)\
\-\ in\\:\\ 0\\.0019509131025011802\ \(0\)\
\-\ and\\:\\ 0\\.0016667500530760967\ \(0\)\
